PUMA BIOTECHNOLOGY, INC. Balance Sheet
PBYI|9 years of annual SEC 10-K data (FY2017-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 9 fiscal years. All figures from audited SEC 10-K filings.
PUMA BIOTECHNOLOGY, INC. had $216M in total assets and $92M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $29.6M | $69.2M | $84.6M | $76.2M | $63.1M | $85.3M | $60.0M | $108.4M | $81.7M |
| Accounts Receivable | $53.7M | $32.0M | $47.8M | $40.4M | $32.5M | $25.5M | $28.9M | $20.8M | $9.7M |
| Inventory | $5.5M | $8.7M | $7.1M | $4.5M | $7.1M | $3.5M | $3.2M | $2.6M | $2.0M |
| Current Assets | $162.7M | $147.7M | $156.2M | $134.3M | $140.0M | $146.1M | $166.3M | $203.0M | $106.4M |
| PP&E (Net) | $187.0K | $515.0K | $855.0K | $1.1M | $1.8M | $2.5M | $3.3M | $4.0M | $4.5M |
| Total Assets | $216.3M | $213.3M | $230.5M | $222.1M | $226.6M | $244.2M | $234.9M | $259.1M | $165.5M |
| Current Liabilities | $81.3M | $96.1M | $99.4M | $77.5M | $109.6M | $114.3M | $90.8M | $67.1M | $58.3M |
| Total Debt | - | $21.7M | $65.7M | $98.3M | $97.1M | $84.0M | $95.0M | $151.9M | $48.5M |
| Shareholders' Equity | $92.1M | $21.6M | -$2.4M | -$6.0M | $17.5M | $34.3M | $53.3M | $209.8M | $206.0M |